AMG 319 in HPV Positive and Negative HNSCC

Summary

The purpose of this study is to determine whether a drug called AMG 319 has an effect on a patient's own immune response to head and neck cancer squamous cell carcinoma (HNSCC). This study is specifically for patients who are having surgery to treat their HNSCC

Timeline

Start

2015-10

Primary completion

2018-05-03

Completion

2018-05-03

Outcome

Outcome not reported

Stopped: “Safety Reasons”

Drugs

Indications